PCDL
Search documents
第11届生物基大会暨展览丨40+名企已报名DT新叶奖!第二轮报名开启,截止3月13日
DT新材料· 2026-02-13 16:04
截止目前,已有 40+家 上市和代表性企业报名参选 2026DT新叶奖 , (点击企业名字,详见独家宣传) : 生物基 材料、制 品和应用 : 万华化学 、 双枪科技 、 裕同科技 、 光华伟业 、 利夫生物 、 中科国生 、 京博中聚 、 播下科技 、树合科技、 和塑 美 、 拜科瑞生物 、 碧嘉材料 、深圳职业技术大学、普拉斯新材、 军安绿色新材料 、漂莱特、碳和新材… 关键词| DT新叶奖 ! DT新叶奖 (DT New Leaf Award)是由DT新材料、生物基能源与材料联合举办的全球化、 专业性、综合性奖项,专注于生物基领域创新,被誉为" 生物基行业的奥斯卡 "。 四大奖项 : 创新材料奖、创新应用奖、最具商业价值奖、创新行业解决方案奖。 免费报名截止 : 3月13日。 生物基化学品/添加剂/能源 :华润双鹤、 糖能科技 、 聚维元创 、 骐业科技 、 浩森生物 、 华呋新材 、 世倍尔 、麒祥材料、 凤登绿能 、 赛泓环 境 、德渊化工、百葵锐、道生生物、 华澄生物 、博辉合生、唯铂莱、 元一生物 、合碳创物… 解决方案(设备/检测/认证/工艺 ) : 科幂仪器 、 霍桐仪器 、 羽时生物 、 ...
元利科技(603217)2025半年报点评:利润率同比提升 多项目即将投产或放量
Xin Lang Cai Jing· 2025-09-12 08:28
Core Viewpoint - The company reported its 2025 semi-annual results, showing a slight decline in revenue but an increase in net profit, indicating resilience in profitability despite challenging market conditions [1]. Financial Performance - In H1 2025, the company achieved revenue of 1.116 billion yuan, a year-on-year decrease of 1.69%, while net profit attributable to shareholders was 108 million yuan, up 0.22% year-on-year. The non-recurring net profit was 106 million yuan, reflecting a 9.08% increase year-on-year. Earnings per share (EPS) stood at 0.52 yuan [1]. - For Q2 2025, revenue was 572 million yuan, down 1.92% year-on-year but up 5.00% quarter-on-quarter. Net profit for Q2 was 61 million yuan, a year-on-year increase of 17.64% and a quarter-on-quarter increase of 30.77% [1]. Product Performance - The company experienced stable growth in product sales, with a notable increase in the production and sales of dimethyl succinate, while the sales of plasticizers declined [2]. - In H1 2025, the production of dimethyl succinate was 60,300 tons (up 10.98% year-on-year), with sales of 59,700 tons (up 6.01% year-on-year). The production of plasticizers was 26,400 tons (up 0.35% year-on-year), but sales fell to 23,900 tons (down 13.72% year-on-year). The production of fatty alcohols was 25,600 tons (up 6.30% year-on-year), with sales of 26,000 tons (up 12.35% year-on-year) [2]. Pricing and Profitability - Despite a decline in product prices, the overall profit margin improved, primarily due to a greater reduction in raw material costs compared to product prices. The high-margin product PCDL contributed to the overall increase in gross margin [3]. - In H1 2025, the average prices for dimethyl succinate, plasticizers, and fatty alcohols were 7,709 yuan/ton (down 1.50% year-on-year), 8,419 yuan/ton (down 15.79% year-on-year), and 15,369 yuan/ton (down 10.89% year-on-year) respectively. The overall gross margin increased to 17.71%, up 1.12 percentage points year-on-year, while the net margin was 9.64%, up 0.18 percentage points year-on-year [3]. Business Expansion and Capacity - The company is expanding its business and capacity with multiple projects nearing production, including a 35,000 tons/year hindered amine light stabilizer project that has entered trial production, and ongoing construction of a 30,000 tons/year glycol project and a 25,000 tons/year hindered amine light stabilizer project [4]. - As a leading player in niche chemical products, the company is well-positioned to benefit from cyclical market reversals, with a global leading capacity in mixed dimethyl succinate and domestic leading capacity in fatty alcohols and DCP products [4]. Investment Outlook - The company is a leader in the fine chemicals sector, with significant production capacity in dimethyl succinate, fatty alcohols, and DCP products, benefiting from integrated and scaled advantages. The entry into the bio-based sector opens a second growth curve [5]. - Updated revenue forecasts for 2025-2027 are 2.227 billion yuan, 2.760 billion yuan, and 3.513 billion yuan respectively, with net profits of 244 million yuan, 347 million yuan, and 437 million yuan. The corresponding EPS estimates are 1.17 yuan, 1.67 yuan, and 2.10 yuan, with price-to-earnings ratios of 18, 12, and 10 times based on the closing price of 20.82 yuan on September 11 [5].